H. Nagashima

发表

Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine.

S. Hosoda, T. Sumiyoshi, Y. Tsurumi, 1995, Journal of the American College of Cardiology.

FGF-1 enhanced cardiogenesis in differentiating embryonal carcinoma cell cultures, which was opposite to the effect of FGF-2.

T. Quertermous, R. Matsuoka, M. Kawana, 2003, Journal of molecular and cellular cardiology.

Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall.

N. Hagiwara, M. Kawana, H. Kasanuki, 2004, Journal of vascular surgery.

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.

N. Hagiwara, M. Kawana, H. Kasanuki, 2002, Journal of vascular surgery.

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects.

N. Hagiwara, M. Kawana, H. Kasanuki, 2002, British journal of clinical pharmacology.

An implantable defibrillator with dual-chamber pacing for a dialysis patient with diminished cardiac function following coronary artery bypass grafting and mitral valve replacement and maintenance of an acceptable level of activities of daily living

K. Nitta, T. Akiba, K. Sagara, 2009 .

Expression of Peroxisome Proliferator-Activated Receptor-&ggr; in Vascular Smooth Muscle Cells Is Upregulated in Cystic Medial Degeneration of Annuloaortic Ectasia in Marfan Syndrome

H. Kasanuki, Y. Sakomura, T. Nishikawa, 2002, Circulation.

An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats.

N. Hagiwara, M. Kawana, H. Kasanuki, 2002, Journal of vascular surgery.

Electrical Connections between Persistent Left Superior Vena Cava and Left Atrium during Catheter Ablation for Atrial Tachycardia

M. Endo, K. Kanmatsuse, H. Nagashima, 2008 .

The status of lipid management in 1,836 patients with coronary artery disease: a multicenter survey to evaluate the percentage of Japanese coronary artery disease patients achieving the target low-density lipoprotein cholesterol level specified by the Japan Atherosclerosis Society.

H. Kasanuki, H. Nagashima, 2005, Journal of atherosclerosis and thrombosis.

Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects

M. Endo, H. Nagashima, 2011, Heart and Vessels.

Cardiac-Specific Overexpression of Cyclin-Dependent Kinase 2 Increases Smaller Mononuclear Cardiomyocytes

P. Kang, B. Lorell, A. Usheva, 2001, Circulation research.

Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice.

N. Hagiwara, M. Kawana, H. Kasanuki, 2009, Atherosclerosis.

Therapeutic value of statins for vascular remodeling.

H. Kasanuki, H. Nagashima, 2003, Current vascular pharmacology.

Congestive heart failure after peripheral blood stem cell transplantation: role of cytokines.

H. Nagashima, M. Kawana, H. Kasanuki, 2000, Japanese circulation journal.

First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers

H. Nagashima, T. Tahara, K. Yoshisue, 2014, Cancer Chemotherapy and Pharmacology.

Optimizing a Single Monthly Dose of Risedronate Based on its Weekly Dose in Healthy Japanese Postmenopausal Women

Ichiro Oikawa, H. Nagashima, M. Hirayama, 2017 .

Improvement of cardiac function and neurological remodeling in a patient with tachycardia-induced cardiomyopathy after catheter ablation.

M. Endo, K. Kanmatsuse, H. Nagashima, 2009, Journal of cardiology.

Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study

M. Matsuhisa, Y. Nagai, H. Nagashima, 2020, Diabetes, obesity & metabolism.

Accessory mitral valve tissue causing severe left ventricular outflow tract obstruction in an adult.

M. Kawana, H. Kasanuki, Y. Sakomura, 2004, The Annals of thoracic surgery.

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

Y. Iwamoto, Y. Omori, H. Nagashima, 2000, Diabetes care.

Blood Glucose Response of a Low-Carbohydrate Oral Nutritional Supplement with Isomaltulose and Soluble Dietary Fiber in Individuals with Prediabetes: A Randomized, Single-Blind Crossover Trial

K. Miyaji, H. Nagashima, Kazutaka Oshio, 2022, Nutrients.

alpha-catenin-deficient F9 cells differentiate into signet ring cells.

T. Noda, M. Monden, H. Shiozaki, 1999, The American journal of pathology.

Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects.

R. Bertz, M. Bifano, H. Nagashima, 2015, International journal of clinical pharmacology and therapeutics.

Angiotensin II Type 2 Receptor Mediates Vascular Smooth Muscle Cell Apoptosis in Cystic Medial Degeneration Associated With Marfan’s Syndrome

H. Koyanagi, M. Kawana, H. Kasanuki, 2001, Circulation.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study.

M. Katashima, H. Nagashima, M. Takizawa, 2020, Clinical therapeutics.

Short Communication a-Catenin-Deficient F9 Cells Differentiate into Signet Ring Cells

T. Noda, M. Monden, H. Shiozaki, 1999 .

Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects

M. Togawa, H. Nagashima, H. Yamaya, 2016, Clinical Drug Investigation.

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.

H. Nagashima, M. Suzuki, C. Muto, 2011, Osteoarthritis and cartilage.

Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel.

C. January, M. Furutani, R. Matsuoka, 1999, Circulation.

Functional activity of the CFTR Cl− channel in human myocardium

S. Hosoda, N. Hagiwara, T. Quertermous, 2007, Heart and Vessels.

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes

Y. Iwamoto, Y. Omori, H. Nagashima, 2000 .

KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.

H. Kasanuki, K. Uto, H. Nagashima, 2000, The American journal of cardiology.

The role of cadherin-catenin-cytoskeleton complex in angiogenesis: antisense oligonucleotide of plakoglobin promotes angiogenesis in vitro, and protein kinase C (PKC) enhances angiogenesis through the plakoglobin signaling pathway.

S. Hosoda, M. Kawana, H. Nagashima, 1997, Heart and vessels.

Effect of Sucrose on Amino Acid Absorption of Whey: A Randomized Crossover Trial

H. Nagashima, H. Maruki-Uchida, Minoru Morita, 2022, Metabolites.